Ipratropium Bromide and Albuterol Sulfate Inhalation recall
Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton containing 30 vials ( 6 pouches of 5 - 3 mL vials), Rx only, Manufactured by: Cipla Ltd., Indore SEZ, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-173-53
Why was Ipratropium Bromide and Albuterol Sulfate Inhalation recalled?
Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot # IA30390, Exp 4/30/2025, IA30517, Exp 6/30/ 2025
- Product
- Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton containing 30 vials ( 6 pouches of 5 - 3 mL vials), Rx only, Manufactured by: Cipla Ltd., Indore SEZ, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-173-53
- Recalling firm
- Cipla USA, Inc.
- Quantity
- 59244/3ml FFS packs
- Distribution
- USA nationwide.
- Recall date
- May 1, 2024
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)